Quick Answer
IRONWOOD PHARMACEUTICALS INC reported Operating Income of $98.50 million for fiscal year 2025.
IRONWOOD PHARMACEUTICALS INC Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | $98.50M | +5.8% |
| 2024 | $93.12M | +109.8% |
| 2023 | -$945.43M | -477.7% |
| 2022 | $250.34M | +7.8% |
| 2021 | $232.26M | +62.5% |
| 2020 | $142.94M | +19.0% |
| 2019 | $120.12M | +179.7% |
| 2018 | -$150.67M | -880.7% |
| 2017 | -$15.36M | +70.4% |
| 2016 | -$51.87M | +49.2% |
| 2015 | -$102.09M | +39.7% |
| 2014 | -$169.37M | +32.8% |
| 2013 | -$252.00M | -246.3% |
| 2012 | -$72.76M | -10.0% |
| 2011 | -$66.14M | -8.8% |
| 2010 | -$60.77M | +0.1% |
| 2009 | -$60.82M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $75.48M | +194.4% | +66.6% |
| June 30, 2025 | $45.32M | +81.5% | +255.7% |
| March 31, 2025 | -$29.11M | -364.1% | -213.5% |
| September 30, 2024 | $25.64M | -35.9% | +2.6% |
| June 30, 2024 | $24.98M | +102.3% | +126.7% |
| March 31, 2024 | $11.02M | -81.7% | -72.5% |
| September 30, 2023 | $40.02M | -41.5% | +103.7% |
| June 30, 2023 | -$1.08B | -2046.2% | -1902.3% |
- IRONWOOD PHARMACEUTICALS INC showed an increase of +5.8% in Operating Income compared to the prior fiscal year.
- Over the 2009–2025 period, IRONWOOD PHARMACEUTICALS INC’s operating income has grown by 262.0% (from -$60.82 million to $98.50 million).
- The most recent figure is from IRONWOOD PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: